<DOC>
	<DOCNO>NCT01043536</DOCNO>
	<brief_summary>The main goal study evaluate determine dose highly accurate irradiation ( allow increase dose deliver restrict risk complication ) association temozolomide .</brief_summary>
	<brief_title>Dose Escalation Radiotherapy With Modulation Intensity Integrated Boost ( SIB-IMRT ) Treatment Glioblastomas Adults</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Histopathologically proven diagnosis glioblastoma ( WHO grade IV astrocytoma ) Diagnosis must obtain stereotactic surgical biopsy Age 18 70 Total partial surgical resection deem possible neurosurgeon OMS performance status 0 1 Adequate blood function : absolute neutrophil count &gt; 1.5 x 109/L , platelet count &gt; 100 x 109/L platelet ; Adequate liver function : bilirubin &lt; 1.5 ULN ( upper limit normal ) , ALT AST &lt; 3 ULN , Adequate renal function : creatinine &lt; 1.5 ULN Patient must inform must sign specific inform consent form . malignancy histology resection brain tumor complete MRI exploration patient unable give inform consent patient present counterindication MRI exploration patient must receive neither radiotherapy chemotherapy affection concomitant malignancy patient already enrol another biomedical study experimental molecule pregnant , nurse woman , without contraception private individual freedom tutelage ( include legal guardianship ) psychiatric , behavioural disorder geographical situation preclude administration followup protocol ( include claustrophobia )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>IMRT</keyword>
	<keyword>Radiotherapy escalation dose</keyword>
	<keyword>glioblastoma</keyword>
	<keyword>escalation radiotherapy dose</keyword>
</DOC>